Drugs / NSV0001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02955030 | Oct 2016 → Mar 2017 | influenza | Nitto Denko Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NSV0001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02955030 ↗ |
| Modality | Vaccine | “NSV0001 is a quadrivalent influenza vaccine with the new adjuvant (ND002) administered by sublingual route.” NCT02955030 ↗ |
| Route | Other | “administered by sublingual route” NCT02955030 ↗ |